|
1
|
Meguid El, Nahas A and Bello AK: Chronic
kidney disease: The global challenge. Lancet. 365:331–340. 2005.
View Article : Google Scholar
|
|
2
|
Barnes JL and Glass WF II: Renal
interstitial fibrosis: A critical evaluation of the origin of
myofibroblasts. Contrib Nephrol. 169:73–93. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chuang PY, Menon MC and He JC: Molecular
targets for treatment of kidney fibrosis. J Mol Med (Berl).
91:549–559. 2013. View Article : Google Scholar
|
|
4
|
López-Hernández FJ and López-Novoa JM:
Role of TGF-β in chronic kidney disease: An integration of tubular,
glomerular and vascular effects. Cell Tissue Res. 347:141–154.
2012. View Article : Google Scholar
|
|
5
|
Gewin L and Zent R: How does TGF-β mediate
tubulointerstitial fibrosis? Semin Nephrol. 32:228–235. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koesters R, Kaissling B, Lehir M, Picard
N, Theilig F, Gebhardt R, Glick AB, Hähnel B, Hosser H, Gröne HJ
and Kriz W: Tubular overexpression of transforming growth
factor-beta1 induces autophagy and fibrosis but not mesenchymal
transition of renal epithelial cells. Am J Pathol. 177:632–643.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moon JA, Kim HT, Cho IS, Sheen YY and Kim
DK: IN-1130, a novel transforming growth factor-beta type I
receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in
obstructive nephropathy. Kidney Int. 70:1234–1243. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Douthwaite JA, Johnson TS, Haylor JL,
Watson P and El Nahas AM: Effects of transforming growth
factor-beta1 on renal extracellular matrix components and their
regulating proteins. J Am Soc Nephrol. 10:2109–2119.
1999.PubMed/NCBI
|
|
9
|
García-Sánchez O, López-Hernández FJ and
López-Novoa JM: An integrative view on the role of TGF-beta in the
progressive tubular deletion associated with chronic kidney
disease. Kidney Int. 77:950–955. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Inazaki K, Kanamaru Y, Kojima Y, Sueyoshi
N, Okumura K, Kaneko K, Yamashiro Y, Ogawa H and Nakao A: Smad3
deficiency attenuates renal fibrosis, inflammation, and apoptosis
after unilateral ureteral obstruction. Kidney Int. 66:597–604.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kosaki K, Bassi MT, Kosaki R, Lewin M,
Belmont J, Schauer G and Casey B: Characterization and mutation
analysis of human LEFTY A and LEFTY B, homologues of murine genes
implicated in left-right axis development. Am J Hum Genet.
64:712–721. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meno C, Ito Y, Saijoh Y, Matsuda Y,
Tashiro K, Kuhara S and Hamada H: Two closely-related left-right
asymmetrically expressed genes, lefty-1 and lefty-2: Their distinct
expression domains, chromosomal linkage and direct neuralizing
activity in Xenopus embryos. Genes Cells. 2:513–524. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meno C, Saijoh Y, Fujii H, Ikeda M,
Yokoyama T, Yokoyama M, Toyoda Y and Hamada H: Left-right
asymmetric expression of the TGF beta-family member lefty in mouse
embryos. Nature. 381:151–155. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ulloa L and Tabibzadeh S: Lefty inhibits
receptor-regulated Smad phosphorylation induced by the activated
transforming growth factor-beta receptor. J Biol Chem.
276:21397–21404. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mason JM, Xu HP, Rao SK, Leask A, Barcia
M, Shan J, Stephenson R and Tabibzadeh S: Lefty contributes to the
remodeling of extracellular matrix by inhibition of connective
tissue growth factor and collagen mRNA expression and increased
proteolytic activity in a fibrosarcoma model. J Biol Chem.
277:407–415. 2002. View Article : Google Scholar
|
|
16
|
Li Y, Zhang J, Fang L, Luo P, Peng J and
Du X: Lefty A attenuates the TGF-beta1-induced epithelial to
mesenchymal transition of human renal proximal epithelial tubular
cells. Mol Cell Biochem. 339:263–270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mariasegaram M, Tesch GH, Verhardt S,
Hurst L, Lan HY and Nikolic-Paterson DJ: Lefty antagonises
TGF-beta1 induced epithelial-mesenchymal transition in tubular
epithelial cells. Biochem Biophys Res Commun. 393:855–859. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sorensen I, Susnik N, Inhester T, Degen
JL, Melk A, Haller H and Schmitt R: Fibrinogen, acting as a mitogen
for tubulointerstitial fibroblasts, promotes renal fibrosis. Kidney
Int. 80:1035–1044. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li L, Zepeda-Orozco D, Black R and Lin F:
Autophagy is a component of epithelial cell fate in obstructive
uropathy. Am J Pathol. 176:1767–1778. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Tang M, Xu Y, Julian J, Carson D and
Tabibzadeh S: Lefty is expressed in mouse endometrium in estrous
cycle and peri-implantation period. Hum Reprod. 20:872–880. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tabibzadeh S and Hemmati-Brivanlou A:
Lefty at the crossroads of ʻstemness' and differentiative events.
Stem Cells. 24:1998–2006. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Besser D: Expression of nodal, lefty-a and
lefty-B in undifferentiated human embryonic stem cells requires
activation of Smad2/3. J Biol Chem. 279:45076–45084. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miyajima A, Chen J, Lawrence C, Ledbetter
S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, et al:
Antibody to transforming growth factor-beta ameliorates tubular
apoptosis in unilateral ureteral obstruction. Kidney Int.
58:2301–2313. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cornet PB, Galant C, Eeckhout Y, Courtoy
PJ, Marbaix E and Henriet P: Regulation of matrix
metallopro-teinase-9/gelatinase B expression and activation by
ovarian steroids and LEFTY-A/endometrial bleeding-associated factor
in the human endometrium. J Clin Endocrinol Metab. 90:1001–1011.
2005. View Article : Google Scholar
|
|
26
|
Zhang YE: Non-Smad pathways in TGF-beta
signaling. Cell Res. 19:128–139. 2009. View Article : Google Scholar :
|
|
27
|
Lan HY: Diverse roles of TGF-β/Smads in
renal fibrosis and inflammation. Int J Biol Sci. 7:1056–1067. 2011.
View Article : Google Scholar
|
